BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1309870)

  • 21. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
    Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
    J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
    Olins GM; Chen ST; McMahon EG; Palomo MA; Reitz DB
    Mol Pharmacol; 1995 Jan; 47(1):115-20. PubMed ID: 7838120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF; Slivjak MJ; Eckardt RD; Newton JF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist.
    Aiyar N; Baker E; Vickery-Clark L; Ohlstein EH; Gellai M; Fredrickson TA; Brooks DP; Weinstock J; Weidley EF; Edwards RM
    Eur J Pharmacol; 1995 Sep; 283(1-3):63-72. PubMed ID: 7498322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
    Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
    Olins GM; Corpus VM; McMahon EG; Palomo MA; Schuh JR; Blehm DJ; Huang HC; Reitz DB; Manning RE; Blaine EH
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists.
    Zhang J; Entzeroth M; Wienen W; Van Meel JC
    Eur J Pharmacol; 1992 Jul; 218(1):35-41. PubMed ID: 1397034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308.
    Chiu AT; Carini DJ; Johnson AL; McCall DE; Price WA; Thoolen MJ; Wong PC; Taber RI; Timmermans PB
    Eur J Pharmacol; 1988 Nov; 157(1):13-21. PubMed ID: 3234494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central and peripheral actions of a nonpeptidic angiotensin II receptor antagonist.
    Koepke JP; Bovy PR; McMahon EG; Olins GM; Reitz DB; Salles KS; Schuh JR; Trapani AJ; Blaine EH
    Hypertension; 1990 Jun; 15(6 Pt 2):841-7. PubMed ID: 2190928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.